Cisatracurium in Acute Respiratory Distress Syndrome
نویسندگان
چکیده
منابع مشابه
LETTER TO THE EDITOR Potential Hazards of Neuromuscular Blocking Agents in the Treatment of Acute Respiratory Distress Syndrome. Comment on: “Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome”
While the mechanisms responsible for the adjusted mortality benefit reported by Papazian et al. remain speculative, it is highly likely that lower transpulmonary pressures (TPPs) in the cisatracurium group were responsible for some portion of the reported benefit. This is suggested by the three-fold incidence of pneumothorax in the placebo group compared to the cisatracurium group despite no di...
متن کاملLung protection strategy as an effective treatment in acute respiratory distress syndrome
Lung protection strategy as an effective treatment in acute respiratory distress syndrome
متن کاملNeuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials
INTRODUCTION Randomized trials investigating neuromuscular blocking agents in adult acute respiratory distress syndrome (ARDS) have been inconclusive about effects on mortality, which is very high in this population. Uncertainty also exists about the associated risk of ICU-acquired weakness. METHODS We conducted a systematic review and meta-analysis. We searched the Cochrane (Central) databas...
متن کاملBenefits of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome Patients: What Is the Evidence?
NMBAs are commonly used in ARDS (25–55% of patients), but the benefits and the risks of using these agents are controversial. Recent data suggest that a continuous infusion of cisatracurium during the first 48 h of ARDS, particularly for patients with a PaO2/FiO2 ratio less than 120, can decrease 90-day inhospital mortality. NMBAs do not appear to be an independent risk factor for ICU-acquired ...
متن کاملValidity of Spo2/Fio2 Ratio in Detection of Acute Lung Injury and Acute Respiratory Distress Syndrome
Introduction: One ofdiagnostic criteria for Acute Lung Injury and Acute Respiratory Distress Syndrome is pao2/fio2 (PF) ratio 300 for ALI or 200 for ARDS. This criteria requires invasive arterial sampling. Measurement of Spo2/Fio2 (SF) ratio by pulseoximetry may be a reliable non invasive alternative to the PF ratio. Methods and Materials: In a cross sectional study we enrolled 105 sample o...
متن کامل